Physician profile
Pradeepto Ghosh
NPI 1851679690
$1,594.35
in general payments reported to CMS, 2019-2025
18 companies · $312 in 2025
The $312 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $743 · 2020: $133 · 2021: $99.45 · 2023: $96.46 · 2024: $210 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $618.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $305.52 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $273.92 | 2019-2025 | Lifevest |
| Pfizer INC. | $164.39 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $151.14 | 2019-2025 | Camzyos, Eliquis |
| Heartflow, INC. | $146.03 | 2025 | |
| Boston Scientific Corporation | $116.59 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $82.18 | 2020-2025 | Uptravi, Opsynvi, Opsumit |
| Amgen INC. | $58.04 | 2019-2024 | Repatha |
| Sanofi-Aventis U.S. LLC | $48.91 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $48.36 | 2019-2024 | Dupixent |
| Janssen Pharmaceuticals, INC | $41.24 | 2019 | |
| Astellas Pharma US INC | $39.47 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.69 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $24.41 | 2025 | Assure Wcd |
| Philips North America LLC | $21.89 | 2024 | (Ck4) Mcot |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuwellis, INC. | $15.93 | 2019 | |
| Abbott Laboratories | $15.52 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pradeepto Ghosh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.